View drug registration information details.
Items | Registration information |
ID | 2181 |
No | 2181 |
Brand Name | DELANZ CAPSULE 30 MG |
Ingredients | DEXLANSOPRAZOLE PELLETS EQ.TO DEXLANSOPRAZOLE 30 MG |
Dosage Form | CAPSULES |
Primary Packaging | ALU-ALU BLISTER |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 2 X 7'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | INDICATED IN ADULTS FOR HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS FOR UP TO EIGHT WEEKS, IN ADULTS TO MAINTAIN HEALING OF EE AND RELIEF OF HEARTBURN FOR UP TO SIX MONTHS, FOR THE TREATMENT OF HEARTBUTN ASSOCIATED WITH SYMPTOMATIC NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE FOR 4 WEEKS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OPAQUE WHITE COLOR BODY/BLUE COLOR CAP, HARD GELATIN CAPSULE #3, CONTAINING WHITE TO OFF WHITE COLOR SPHERIACAL PELLETS |
Note | |
License Owner | POUNSAB PHARMA CO.,LTD |
Manufacturer | THE SEARLE COMPANY LIMITED |
Country | PAKISTAN |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 05 I 5506/23 |
FDD Registration Date | 09-MAY-2023 |
Expiry Date | 08-MAY-2026 |
Back to drug list
|